Categories
Health

Airstrike Damages Gaza’s Solely Covid-19 Testing Lab, Officers Say

Since Covid-19 first appeared in the blocked Gaza Strip, the authorities have only been able to conduct a relatively small number of coronavirus tests due to the lack of medical care.

Now the only laboratory in Gaza processing test results is temporarily inoperable after an Israeli air strike nearby on Monday, Gaza officials said.

The strike, which targeted a separate building in Gaza City, sent splinters and debris flying across the street and damaged the laboratory and administrative offices of the Hamas-led health ministry, said Dr. Majdi Dhair, Director of the Department of Preventive Medicine at the Ministry.

A ministry official was hospitalized and in serious condition after being hit in the head by a splinter, said Dr. Dhair on Tuesday in a telephone interview.

“This attack was barbaric,” he said. “There’s no way to justify it.”

The Israeli army did not immediately respond to a request for comment on the strike. Since Israel began its bombing campaign in Gaza on May 10, the army has declared that its air strikes are aimed exclusively at militants and their infrastructure.

Dr. Dhair said he believed the equipment in the lab was intact, but stressed that it would take at least a day to clean up the damage and prepare him to run coronavirus tests again. In the meantime, the medical teams would stop doing tests.

Rami Abadla, director of the Infection Control Department of the Gaza Ministry, said the laboratory will also temporarily not be able to process results for other tests related to HIV, hepatitis C and other diseases.

Over the past week, Gaza authorities tested an average of 515 Palestinians for the virus every day. According to official data, only 1.9 percent of the two million people in Gaza were fully vaccinated on Monday, compared with 56 percent in Israel.

After an increase in cases in April, mainly due to the highly communicable coronavirus variant first identified in the UK, new infections in Gaza have recently dropped to manageable levels, health experts said. But with Israeli air strikes destroying buildings, causing widespread damage and killing more than 200 people by Monday, United Nations officials have warned coronavirus cases could re-emerge.

Unvaccinated Palestinians crowded into schools operated by the United Nations Relief Society in Gaza, turning them into de facto air raid shelters. Matthias Schmale, the head of operations at the UN agency, said last week that these schools “could become mass disseminators”.

Mr Schmale and the World Health Organization’s chief official in Gaza, Sacha Bootsma, also said that all vaccinations stopped when hostilities broke out and that any vaccine supply in the territory had been delayed by the closure of the border crossings in the Gaza Strip.

Categories
Health

Vacunas para la COVID-19: ¿debo ponerme la segunda dosis?

However, the agency warned unvaccinated people that they are at greater risk – and should continue to wear face masks – if they go to the movies indoors, dine in a restaurant or bar, take high-intensity exercise classes indoors, or sing in a restaurant choir indoors . Rochelle Walensky, the director of the CDC, noted that the risk of spreading the virus indoors increases almost 20 times.

Updated

May 13, 2021 at 7:22 AM ET

And even for vaccinated people, he stated, “Until there are no more vaccinated people and we continue with more than 50,000 cases a day, wearing masks indoors provides additional protection.”

There are good reasons to be careful. More than half of the population, including children, are still not immunized. It is not known whether immunized people can become infected with the virus and have no symptoms and then accidentally spread it to other vulnerable people. Not everyone who wants to get vaccinated can do so for logistical or health reasons, and vaccines may not fully protect people with immunodeficiency.

Even if approved vaccines produce a stronger immune response than natural infections, we still don’t know how long their protection will last. The Excelsior Pass I was given in New York State confirms my vaccination status but will expire in mid-August, six months after my second dose, when I may need a booster to maintain my immunity.

Speaking of which, no one should stop getting that second dose of Pfizer or Moderna vaccines. While taking a few weeks to get the second is probably not all that important, the immune response is relatively weak after a dose and could leave people vulnerable, especially to the more virulent variants that are now floating around.

Two doses are 90 percent effective at preventing infection, and that protection is likely to last much longer. You should be scheduled for the second dose when you sign up for the first dose or when you receive it.

Some people hesitate to take the second dose because they have heard that the side effects can be uncomfortable. No matter how uncomfortable it may be, the vaccine’s side effects are brief and nowhere near as severe or persistent as the disease it protects you from. Even after recovering from a mild case of COVID-19, annoying imprints such as disorientation and chronic fatigue can be left behind.

Categories
Health

Seychelles most vaccinated nation on Earth however Covid-19 has surged

A woman with an umbrella walks in a street in the capital Victoria of the Seychelles.

Valery Sharifulin | TASS | Getty Images

Seychelles worries world health experts after a surge in Covid-19 cases in fully vaccinated people.

The World Health Organization announced Tuesday that it would review coronavirus data from the Seychelles, an archipelago of 115 islands in the Indian Ocean, after the Ministry of Health said in the week leading up to May 8 that more than a third of people were positive tested for Covid-19 had been fully vaccinated.

It is believed that the Seychelles have so far carried out a very successful vaccination rollout. It can boast of having the highest percentage of people vaccinated against Covid-19 in the world, above Israel and the UK

The majority of people vaccinated have received China’s Sinopharm vaccine (approved by WHO for emergency use last Friday) as well as the AstraZeneca shot (known locally as Covishield, a version made in India). Overall, the Seychelles, with a population of over 97,000, recorded just under 8,200 cases and 28 deaths during the pandemic.

On Monday, the Seychelles Ministry of Health reported a sharp increase in the number of cases. Of the 120 new cases reported on April 30, a week later, over 300 cases were recorded a day on May 7 and May 8, respectively.

Of all positive cases, the Department of Health said 63% were either not vaccinated or were only given a dose of SinoPharm or Covishield, but 37% of new infections were in people who received both doses.

The ministry found that 80% of patients in need of hospital treatment had not been vaccinated and were more likely to be people with comorbidities. It added that “almost all” of the critical and severe cases requiring intensive care had also not been vaccinated. To date, none of the patients who died with Covid-19 had been fully vaccinated.

To date, 57% of those who received two doses have received Sinopharm and 43% have received Covishield, the Seychelles Ministry of Health said. It is unclear which vaccine was given to people who were fully immunized but then tested positive for Covid.

While new cases flattened on May 7 and 8 (with 317 new cases reported and 314 cases), the Ministry of Health said, “The transmission rate remains high and is worrying.”

The situation has certainly alarmed experts, especially since 60% of the total population of Seychelles has been fully vaccinated. In addition, 86% of the Seychelles target population for vaccination – 70,000 people – have been fully vaccinated to date, according to data from the ministry.

What the WHO thinks

On Monday, WHO director for Immunization, Vaccines and Biologics, Dr. Kate O’Brien, in a briefing, that the WHO is in direct communication with the Ministry of Health of the Seychelles and that the situation is “a more complicated situation than the top situation”. Line messages. “

“As mentioned earlier, the vaccines are very effective against severe cases and deaths. Most of the cases are mild cases. What is also important is that a significant proportion, over 80% of the population, has been vaccinated. But as we know … occur some of the reported cases occur either shortly after a single dose or shortly after a second dose, or between the first and second dose. “

She said that in this particular situation a very detailed assessment is required, “what the situation is like, first, what pressures are circulating in the country, second, if the cases occur in relation to the time someone has been dosed, third, how.” hard they are of the cases. “

‘Only through this type of assessment can we judge whether or not it is vaccination failure or whether it is more about the nature of the cases occurring, the milder end of the cases, and then the timing of the cases relative to the timing of the doses given to individuals. This assessment is ongoing and we are supporting and working with the country to understand the situation. “

CNBC has asked WHO for an updated comment on the situation in Seychelles but has yet to receive a response.

Effectiveness of the vaccine

The WHO has repeatedly warned that vaccination alone would not be enough to stop the pandemic, but would rather be another weapon in the arsenal to fight the virus.

Restrictions on social contact as well as good personal hygiene are still seen as a basis for preventing the spread. Last week, the Seychelles placed restrictions on some social gatherings and public spaces to curb the spread.

The situation of the islanders is a reminder that no coronavirus vaccine currently in use has been proven to be 100% effective in preventing Covid-19 infection. Still, all vaccines currently approved for use by the WHO have been shown to be very, if not extremely, effective in preventing serious Covid infections, with cases, hospitalizations and deaths falling sharply in countries with advanced vaccination programs like the UK

With a third wave of cases and new virus variants that could lead to further deaths and economic devastation, time is of the essence to get life-saving vaccines approved and distributed worldwide. The more available, the better.

On Friday, the WHO approved the state-owned Chinese pharmaceutical company SinoPharm for emergency use. This could accelerate the use of the shot in the WHO COVAX program, which aims to give poorer countries access to vaccines.

WHO said the addition of the SinoPharm vaccine had “the potential to rapidly accelerate access to Covid-19 vaccines for countries that want to protect health workers and vulnerable populations.”

It noted that the WHO Strategic Advisory Group on Immunization Experts had completed a review of the vaccine and recommended it on a two-dose regimen, three to four weeks apart, for adults aged 18 and over based on all available evidence.

“The effectiveness of the vaccine in symptomatic and hospital illnesses was estimated to be 79%, all ages combined,” it said. However, it was found that “few older adults (over 60 years of age) have participated in clinical trials, so efficacy in this age group could not be estimated”.

In March, AstraZeneca released an updated clinical trial date showing the vaccine is 76% effective against symptomatic Covid-19 infections. Pfizer-BioNTech and Moderna vaccines were found to be 95% effective.

Categories
Health

Covid-19 Vaccines: Novavax Stories Extra Delays

Novavax, one of the earliest players in the world’s vaccination race against Covid, delivered disheartening news Monday, saying its highly protective vaccine would not be approved in the US or UK until July and would not reach peak production by the end of the year.

The delays announced during a profit call with investors are the most recent setback for the little-known Maryland company that received up to $ 1.6 billion from the federal government last year and its product is in clinical trials has shown robust results. Despite these achievements, the company has struggled to show it can deliver on its promise to bring 2 billion doses to the world this year. Novavax has never launched a vaccine in its 34-year history.

Speaking on the conference call, the company’s President and Chief Executive Officer Stanley C. Erck said the regulatory and manufacturing hurdles causing the delay have now been resolved. “Almost all of the major challenges have been overcome and we can clearly see the light at the end of the tunnel,” he said.

Investors didn’t seem to agree: by Tuesday morning, the company’s stock had fallen to $ 133.86, down nearly 17 percent, although it rebounded a little later in the day.

“I don’t see much good for them right now,” said Rob Smith, general manager of Capital Alpha Partners, an investment research firm.

The company’s delay is unlikely to affect wealthy countries like the US, which are being flushed with vaccines from Moderna, Pfizer-BioNTech, and Johnson & Johnson.

It’s likely that this will have a significant impact on the rest of the world, however, as Novavax only signed a deal with Gavi, a public-private global vaccine partnership, last week to sell 1.1 billion doses of its shot at low and medium levels – to deliver. Income Countries. Novavax has other contracts with countries such as South Korea, Japan and Australia and has agreements with eight manufacturing facilities around the world.

In January, the company estimated it would reach its full production capacity of 150 million cans per month by the middle of this year. This forecast was later revised after a lack of supplies such as filters and the huge disposable bags used in vaccine production. On Monday, the company delayed its estimate again, anticipating production of 100 million cans per month by the end of the third quarter and production of 150 million cans per month by the fourth quarter.

One of its key manufacturing partners, the Serum Institute in India, has faced its own manufacturing and geopolitical challenges. A fire at the facility earlier this year reduced capacity, and in April Adar Poonawalla, director of Serum, urged the United States to restrict access to raw vaccine ingredients. And although Novavax’s contract with serum aims to serve the rest of the world through its agreement with Gavi, the Indian government has banned the export of vaccines from the country as it grapples with a deadly second wave of Covid-19.

“Serum is the backbone of global vaccine supplies,” said Andrea Taylor, associate director of the Duke Global Health Innovation Center, which pursues global vaccine businesses. “I think for countries in South and Southeast Asia in particular, as well as for countries in Africa, it is difficult to overestimate the impact this will have.”

Novavax has also thrown back regulatory hurdles. On Monday, company executives said a problem now resolved with an “assay” – a test that was required to confirm that their product could be consistently manufactured on a commercial scale at multiple factories – was gaining regulatory approvals around the world Delayed countries like the UK and the United States would not give approval until July. The company’s employees once said they were hoping to get approval for their vaccine in April.

The delay is particularly noticeable in the UK, where Novavax reported positive results from its clinical trial in January.

British officials convinced Novavax to set up a study there last year, partly because they promised rapid clinical development and regulatory approval. But time is running out: around two-thirds of UK adults have received an initial dose of a coronavirus vaccine, largely made by AstraZeneca, and each adult is expected to be offered one by the end of July.

Updated

May 11, 2021 at 4:32 p.m. ET

The role of the vaccine in the UK depends in part on how quickly Novavax can start distributing its vaccine. A UK factory that makes the vaccines has announced that they will be ready by the summer. The country recently turned away from AstraZeneca intake in younger people because of the risk of very rare blood clots, so Novavax may be an alternative for people under 40.

The country is also investigating the effects of giving a second dose of the Novavax vaccine to people who have already received a first dose of Pfizer or AstraZeneca.

In the US, the Novavax setback sheds new light on the massive deal with the US government. As recently as 2019, the company was on the verge of closing after another vaccine made a major trial and had to sell its manufacturing facility to raise money.

Last year, the Trump administration placed a big bet on the tiny company as part of its Operation Warp Speed ​​project, signing a $ 1.6 billion contract earlier this year to supply 110 million cans. In April, the total amount of the deal increased to $ 1.75 billion, according to Novavax. The company’s major study in the United States and Mexico is still ongoing, despite executives on Monday that they expected the results of that study “in a few weeks.”

Novavax officials said they now didn’t expect to deliver these doses by the end of this year or early 2022. A Novavax spokeswoman said there was no penalty for later delivery in her contract with the U.S. government.

Novavax’s spotty track record offers no confidence in the challenge of producing billions of cans, said Les Funtleyder, healthcare portfolio manager at E Squared Capital Management, which invests in domestic and emerging markets. “It seems they really weren’t prepared for a challenge of this magnitude,” he said.

Recent news about internal sales – such as the departure of Novavax’s chief financial officer last month, five months after he took office for personal reasons – doesn’t help, Funtleyder said. “It’s a bad look,” he said.

But even if there’s a challenging path to follow as a straggler, Novavax’s vaccine could fill important loopholes, some experts said. In the United States, it could be used as a booster shot to bolster dwindling immunity, or the Biden government could choose to donate the vaccine to other countries in need, as it does with the unused supply of AstraZeneca doses .

Novavax has announced that it will develop a new version of its vaccine to address the variant circulating in South Africa. And it was recently announced that it would be investigating the shot in children over the age of 12 to catch up with Moderna and Pfizer, who have already tested their products in that age group.

The vaccine can also be stored at normal refrigeration temperatures without the freezing temperatures required for Pfizer and Moderna vaccines.

“By the end of 2021, there will still be a great need for safe, effective vaccines that can travel well,” said Ms. Taylor of Duke University. “Novavax seems to fit that description.”

Dr. Saad B. Omer, director of the Yale Institute for Global Health, noted that countries with multiple vaccines available were able to switch to other options when concerns about Johnson & Johnson and AstraZeneca vaccines were raised due to blood clot association.

“It’s good to hedge our bets,” he said. “For example, if we want to avoid one body blow after another in low-income countries in many parts of the world that affects everyone, we have to vaccinate a large part of the world.”

Benjamin Mueller and Noah Weiland contributed to the reporting.

Categories
Business

India’s Serum Institute Struggled to Meet Its Covid-19 Vows

NEW DELHI – Adar Poonawalla made great promises. The 40-year-old boss of the world’s largest vaccine company pledged to take a leading role in the global effort to vaccinate the poor against Covid-19. His India-based empire signed hundreds of millions of dollars in contracts to make cans and export them to suffering countries.

Those promises have fallen apart. India, embroiled in a second wave of coronavirus, is laying claim to its vaccines. Other countries and aid groups are now trying to find scarce doses elsewhere.

At home, politicians and the general public have charged Mr Poonawalla and his company, the Serum Institute of India, with price increases during the pandemic. Serum has had production issues that have prevented it from ramping up production at a time when India needs every dose. He has been criticized for leaving for London in the middle of the crisis, although he said it was only a short trip. He told a British newspaper that he had received threats from politicians and some of India’s “most powerful men” demanding that he provide them with vaccines. When he returns to India, he will travel with government-appointed armed guards.

In an interview with the New York Times, Mr. Poonawalla defended his company and its ambitions. He said he had no choice but to give vaccines to the government. He cited a shortage of raw materials, which he had partly blamed on the United States. The manufacture of vaccines is a laborious process that requires investment and great risks. He said he would return to India when he finished his business in London. He shrugged off his previous comments on threats, saying they were “nothing we cannot deal with”.

But he also admitted that the Serum Institute alone will not be able to vaccinate India anytime soon, let alone bear the burden of vaccinating the world’s poor.

“The problem is, no one took the risk I took early on,” he said. “I wish others had.”

His position is a dramatic turnaround for Serum and the Indian government. In January, when India was launching its own vaccination program and exporting at the same time, Prime Minister Narendra Modi promised that its vaccines would “save humanity”.

Instead, the looming tragedy has made it clear that India – even with the world’s largest vaccine maker – cannot save itself.

India’s long-term vaccination prospects improved after the Biden government on Wednesday supported the waiver of intellectual property protection for vaccines, which could make it easier for Indian factories to manufacture those vaccines. Still, this will not help the current crisis in India, which had claimed more than 230,000 lives as of Friday – a number that is likely to be vastly outnumbered.

Serum won Mr. Modi’s favor in part because it fitted the government’s tale of a separate India poised to take its place among the world’s great powers. Now both Mr Modi’s government and Serum have been humiliated and their ambitions are being challenged.

“Our capacities are extremely poor,” said Manoj Joshi, a staff member at the Observer Research Foundation in New Delhi, which focuses on Indian politics. “We are a poor country. I hope we can build some humility into the system. “

Mr. Poonawalla took over the running of the Serum Institute a decade ago from his father, Cyrus, a horse breeder who became a vaccine billionaire. Before the crisis, he was hailed in the Indian media as an example of a new class of young, secular entrepreneurs. Photos of him and his wife Natasha were a staple of fashion.

Last year Serum signed a contract with AstraZeneca to manufacture one billion doses of its Oxford-AstraZeneca vaccine called Covishield in India. Serum received a $ 300 million grant from the Gates Foundation to deliver up to 200 million doses of Covishield and another vaccine under development to the Gavi Alliance, the public-private partnership that provides Covax, the program for the donation of Vaccines to poor countries, monitored.

According to a review of sales contracts supplied by UNICEF, Serum committed between January and March to sell approximately 1.1 billion doses of vaccine in the coming months. By the time India largely stopped exporting vaccines, Serum had only exported about 60 million doses, about half to Gavi. India had asked for more than 120 million.

Since then, AstraZeneca Serum has issued a legal notice regarding delivery delays. Serum has only “temporarily postponed,” said Poonawalla, citing the Indian government’s export ban.

“That comes from India,” he said. “It is not the supplier who is behind schedule.”

The world is wrestling with the ripple effect. A spokesman for Gavi said India’s decision to prioritize “domestic needs” “has an impact on other parts of the world that are in dire need of vaccines.” Even so, Gavi signed a purchase agreement with an American vaccine company called Novavax on Thursday that included the doses of serum to be administered.

Nepal, India’s northern neighbor, changed its public procurement law to pay serum an 80 percent advance, or around $ 6.4 million, for the purchase of two million cans of Covishield. Serum delivered the first million doses but is offering Nepal its money back for the second million, said Dr. Dipendra Raman Singh, Director of the Nepalese Ministry of Health. Nepal has refused in hopes of getting more doses as India’s disaster bleeds across the border.

Some of India’s needs are self-inflicted. Only two vaccines are made, Serum’s Covishield and one that was developed in India. An intergovernmental agreement to manufacture Russia’s Sputnik V in India is embroiled in bureaucracy. If other manufacturers had started earlier, said Mr Poonawalla, serum might not have been exposed to as much pressure.

Serum’s failure to deliver is also AstraZeneca’s, as it has pledged to Oxford University that the vaccine will be made available to countries that cannot afford it.

“I was very sad that we couldn’t help them, but don’t forget that my first priority is my nation, which has given me everything,” said Poonawalla. “And after all, I’m Indian. I may be a global Indian company, but the fact is we are in India. We have to take care of ourselves just as America has taken care of itself, Europe takes care of itself. “

But serum cannot meet India’s needs either.

Serum planned to split its 50-50 doses between India, either directly or through Covax, and the rest of the world. Serum now accounts for 90 percent of the Indian supply and is still inadequate. Less than 3 percent of the population have been fully vaccinated. In some states, people are turned away from vaccination centers when they run out of doses.

Serum has missed its expansion goals. Mr Poonawalla said last fall that the Serum Institute would pump 100 million doses a month earlier this year, of which about four in ten would go overseas.

Serum capacity remained at around 72 million doses per month after a fire at a facility designed to help the company ramp up vaccine production. A grant of more than $ 200 million from the Indian government should help the company meet its goal by the summer, he said.

Understand India’s Covid Crisis

Mr. Poonawalla has also cited raw material supplies. In April, he called on President Biden on Twitter to lift the embargo on raw materials used to manufacture Covid-19 vaccines. White House officials said Mr. Poonawalla misrepresented his situation. Still, the United States said it would send raw materials to the Serum Institute to increase vaccine production, even though Mr Poonawalla said they had not arrived yet.

Mr Poonawalla has also been investigated for charging different prices to the central government, Indian states and private hospitals. Two weeks ago, Serum said it would charge state governments about $ 5 per dose, about $ 3 more than Mr. Modi’s government.

Last week, after criticism, Mr Poonawalla lowered the price to $ 4. Nonetheless, the critics point to an interview in which Mr Poonawalla said that he was making a profit even at the price of central government.

Mr Poonawalla said that serum could be sold to the Indian central government at a lower price because they were ordering larger quantities.

People don’t understand, ”Poonawalla told the New York Times. “They just take things in isolation and then slander you without realizing that these goods are sold worldwide for $ 20 a dose and we are getting them in India for $ 5 or $ 6. There is no end to cribbing, complaining, criticizing. “

Mr Poonawalla said he had received more than just complaints. His company last month asked the Indian government to keep him safe, citing threats that the company has not made public. The government assigned him a detail two weeks ago that includes four to five armed workers.

In an interview with The Times of London newspaper published last week, he described how he received constant aggressive calls demanding vaccines immediately. “‘Threats’ are an understatement,” he told the newspaper.

He downplayed the threats in his interview with the New York Times, and his office declined to provide further details. Nonetheless, the comments caused an uproar in India. Some politicians have asked him to give names.

In a petition before the Bombay Supreme Court on Wednesday calling for additional security for Mr Poonawalla, Datta Mane, a Mumbai lawyer, said the vaccine tycoon had been threatened by prime ministers – India’s equivalent to governors – and business leaders. The company said it has no relationship with Mr. Mane and was not involved in the petition.

The Times of London reported that the threats had become so ominous that Mr Poonawalla fled India to the UK, an allegation that Mr Poonawalla denied. Instead, he said he was there on a business trip to see his children who attended school there last year.

His presence in London only fueled his critics, who angered the price hikes of serum. Sunil Jain, editor-in-chief of The Financial Express newspaper, tweeted that Poonawalla’s departure to London was “shameful” and that he should cut prices.

The Serum Institute is planning a significant expansion in the UK, investing nearly $ 335 million in research and development to fund clinical trials, expand its sales office and potentially build a manufacturing facility, Poonawalla’s office said.

“Everyone depends on the fact that we can deliver this magical silver ball in an almost infinite capacity,” said Poonawalla. “There is tremendous pressure from state governments, ministers, the public, friends and anyone who wants the vaccine. And I’m just trying to distribute it fairly as best I can. “

Selam Gebrekidan in London and Bhadra Sharma in Kathmandu, Nepal contributed to the coverage.

Categories
Health

In Covid-19 Vaccine Information, LGBTQ Folks Worry Invisibility

Even if some people are reluctant to reveal such data, research shows that clinicians overestimate how many patients would refuse to self-report. A 2017 study found that around 80 percent of doctors felt that patients would be reluctant to provide this data, but only 10 percent of patients said they would refuse to do so.

The Centers for Disease Control and Prevention have also stated that it should be optional for patients to report their gender identity. The ability to report yourself is key, according to proponents. “It’s important that people identify like any other demographic,” said Chris Grasso, vice president of information technology and data services at the Fenway Institute. “We want to normalize data collection – just like we ask people questions about their age, race, or ethnicity.”

LGBTQ advocates have been raising alarm bells throughout the pandemic, writing letters to health organizations and the new government, and asking authorities to report on coronavirus testing, care outcomes and vaccine intake in their communities.

Some states and jurisdictions have started moving forward: Pennsylvania, Rhode Island, and Washington, DC are collecting and reporting some of this data in their Covid-19 monitoring systems. And in September, the Governor of California signed a bill requiring healthcare providers to collect the data for all communicable diseases.

But it wasn’t until March that the California Department of Health hadn’t released its sexual orientation and gender identity statistics. And other officials raising concerns from those trying to keep their sexuality private have expressed concern about the gathering of this information. For example, Colorado Governor Jared Polis, who is gay, said in a discussion with other elected officials in April 2020, “There are a lot of people in Colorado who don’t want this information out there.”

Despite the lack of data, the CDC notes that LGBTQ people may have more severe Covid-19 results than heterosexual people, in part due to a higher prevalence of pre-existing conditions such as heart disease, diabetes, asthma, cancer, obesity and smoking .

Categories
World News

Covid-19 Reside Updates: Vaccines, Variants and Circumstances

Here’s what you need to know:

Credit…Ognen Teofilovski/Reuters

The World Health Organization on Friday approved China’s Sinopharm’s Covid-19 vaccine for emergency use, easing the way for poorer nations to get access to another much-needed shot to help end the pandemic.

The approval allows the Sinopharm vaccine to be included in Covax, the World Health Organization’s global initiative that is designed to promote equitable vaccine distribution around the world.

The need is dire.

Rich countries are hoarding doses. India, a major vaccine maker, has stopped exports to address its worsening coronavirus crisis. Questions about safety after exceedingly rare side effects led some countries to briefly pause using AstraZeneca and Johnson & Johnson doses or change their guidance around the use.

Reliable vaccine access could improve further next week when the W.H.O. considers another Chinese shot, made by the company Sinovac.

Andrea Taylor, who analyzes global data on vaccines at the Duke Global Health Institute, called the potential addition of two Chinese vaccines into the Covax program a “game changer.”

“The situation right now is just so desperate for low- and lower-middle-income countries that any doses we can get out are worth mobilizing,” Ms. Taylor said. “Having potentially two options coming from China could really change the landscape of what’s possible over the next few months.”

But the fanfare may be short-lived. While China has claimed it can make up to 5 billion doses by the end of this year, Chinese officials say the country is struggling to manufacture enough doses for its own population and are cautioning a pandemic-weary world to keep expectations in check.

“This should be the golden time for China to practice its vaccine diplomacy. The problem is, at the same time, China itself is facing a shortage,” said Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations. “So in terms of global access to vaccines, I don’t expect the situation to significantly improve in the coming two to three months.”

Still, the approval represents a high point in its vaccine diplomacy efforts and a chance to fill the gap left by Western nations and pharmaceutical companies in low- and middle-income countries. Sinopharm is the first Chinese shot to be classified as safe and effective by the W.H.O., and its approval could ease concerns about the lack of transparency from Chinese vaccine companies.

Regulators from China and other countries have approved the Sinopharm vaccine in recent months, though the company has not released Phase 3 clinical trial data for scientists to independently assess.

The W.H.O. was given access to this data before the announcement, but there is limited data on how well the vaccine will work against the many coronavirus variants cropping up around the world.

United States › United StatesOn May 6 14-day change
New cases 47,325 –27%
New deaths 818 –4%
World › WorldOn May 6 14-day change
New cases 856,719 Flat
New deaths 13,873 +9%

U.S. vaccinations ›

Where states are reporting vaccines given

Ton Tran, 106, receiving his second dose of the Pfizer-BioNTech Covid-19 vaccine at a clinic in San Jose, Calif., on Thursday.Credit…Noah Berger/Associated Press

Pfizer and the German company BioNTech have become the first companies to apply to the U.S. Food and Drug Administration for full approval of their Covid-19 vaccine for use in people 16 and older. The vaccine is currently being administered to adults in America under an emergency use authorization granted in December.

The approval process is likely to take months.

The companies said in a statement on Friday that they had submitted their clinical data, which includes six months of information on the vaccine’s safety and efficacy, to the F.D.A. They plan to submit additional material, including information about the manufacturing of the vaccine, in the coming weeks.

“We are proud of the tremendous progress we’ve made since December in delivering vaccines to millions of Americans, in collaboration with the U.S. government,” Dr. Albert Bourla, Pfizer’s chief executive, said in the statement. “We look forward to working with the F.D.A. to complete this rolling submission and support their review, with the goal of securing full regulatory approval of the vaccine in the coming months.”

As of Thursday, more than 134 million doses of the vaccine had been administered in the United States, according to the Centers for Disease Control and Prevention. Full approval would allow Pfizer and BioNTech to market the vaccine directly to customers.

It could also make it easier for companies, government agencies and schools to require vaccinations. The Equal Employment Opportunity Commission said in December that employers could mandate vaccination, and legal experts have generally agreed.

Many companies have been hesitant to require the vaccines, especially while they have only emergency authorization, which is designed to be temporary. Some institutions, like the University of California and California State University systems, have said that they would do so only after a vaccine has full approval.

Full approval could also prompt the U.S. military, which has had low uptake of Covid-19 vaccines, to mandate vaccinations for service members.

If the F.D.A. grants full approval, it could also help raise confidence in the vaccine. The pace of vaccination has slowed in the United States in recent weeks, and a recent national survey indicated that most people in the country who planned to get the shots had already done so.

The agency is also expected to issue an emergency authorization for use of the Pfizer-BioNTech vaccine in 12- to 15-year-olds next week. The companies have said that they plan to file for emergency authorization for 2- to 11-year-olds in September.

Moderna plans to apply for full approval for its Covid-19 vaccine this month, the company said during its quarterly earnings call on Thursday.

Director of the Center for the National Center for Immunization and Respiratory Diseases Dr. Nancy Messonnier spoke in Washington in January 2020.Credit…Amanda Voisard/Reuters

Dr. Nancy Messonnier, who famously warned the nation early last year that the coronavirus would upend their lives, resigned from her position at the Centers for Disease Control and Protection on Friday.

Dr. Messonnier’s resignation is effective May 14. She is taking on a new role as an executive director at the Skoll Foundation, a philanthropical organization based in Palo Alto, Calif., she told staff in an email on Friday.

Her exit may augur more changes at the agency. Reports have circulated for weeks that the C.D.C.’s new director, Dr. Rochelle Walensky, planned to completely reorganize the division Dr. Messonnier led.

“My family and I have determined that now is the best time for me to transition to a new phase of my career,” Dr. Messonnier wrote in the email to staff.

Dr. Messonnier began her career in public health in 1995 with a stint in the prestigious Epidemic Intelligence Service. She has since held a number of leadership posts in the C.D.C. Since 2016, she has served as director of the National Center for Immunization and Respiratory Diseases, the C.D.C. division responsible for managing influenza and other respiratory threats.

In late 2019, she became the agency’s lead in responding to the coronavirus, and initially shared a stage with President Trump at briefings about the coronavirus.

She fell out of favor with President Trump and sent stocks tumbling after she sounded a dire alarm about the coronavirus, saying it would disrupt the lives of every American.

“It’s not a question of if this will happen but when this will happen and how many people in this country will have severe illnesses,” she said on Feb. 25, just as Mr. Trump was boarding Air Force One in New Delhi for his flight home.

Soon after that, she stopped appearing at briefings of the White House and of the C.D.C.

Patients with Covid-19 in the emergency ward at the Holy Family hospital in New Delhi on Thursday.Credit…Rebecca Conway/Getty Images

India’s worsening coronavirus outbreak has spread far outside its cities to rural areas with poor health care infrastructure and limited testing capacities, doctors and experts say.

One factor behind the surge of cases, they believe, is a series of recent campaign rallies held without social distancing.

The state of West Bengal, where Prime Minister Narendra Modi’s party lost an election last week after more than a month of campaigning to vast crowds, is recording the highest rate of positive coronavirus tests in the country. More than 31 percent of tests in the state are now coming back positive.

“There is a clear pattern here: States that went through elections and where large rallies were held are witnessing a huge rise in cases,” said Dr. Thekkekara Jacob John, a senior virologist in the southern state of Tamil Nadu.

In Uttar Pradesh, India’s most populous state, 1,028 new coronavirus cases and four deaths were recorded on March 26. On April 29, after campaigns for local village council elections were held, there were 35,104 cases and 288 deaths. A teachers’ union in the state said that 577 teachers and support staff members who were on duty as election workers had died of Covid-19.

The country’s cases as a whole have been skyrocketing since late March, from a seven-day average of more than 62,000 on March 31 to more than 385,000, according to the Our World in Data project at the University of Oxford. On Friday, the country reported more than 410,000 new daily infections, a record, and more than 3,900 deaths.

As the outbreak reaches new heights, India’s vaccination campaign has slowed down, marred by supply shortages and competition among states.

The official daily death in the country has stayed over 3,000 over the past 10 days, and experts say the numbers are much higher,.

The true scope of the outbreak remains hard to measure. Nationwide, India conducted about 1.9 million coronavirus tests on Thursday, an increase from about 1.2 million daily tests last month, but hardly enough to keep up with a daily caseload that has almost quadrupled in that time.

West Bengal, a state of 90 million people that has poor health care infrastructure and is under a partial lockdown, has carried out fewer than 60,000 coronavirus tests a day. That is one of the lowest rates in the country, according to data compiled by researchers at the University of Michigan.

Dr. Abhijeet Barua, a physician in Kolkata, the state’s capital, said that cases had exploded in every corner of the city and that infections were spreading quickly in the state’s rural areas. At his 10-bed clinic, two people have died every day over the past 15 days, Dr. Barua said.

“What is making things worse in Kolkata is that over 70 percent of the population lives in close contact,” he said, adding that he was receiving dozens of calls a day from patients seeking help. “You can’t isolate yourself, because it is so congested here.”

Mr. Modi has repeatedly refrained from imposing a nationwide lockdown. Instead nearly a dozen of India’s 28 states have imposed restrictions, though they are less stringent than the nationwide lockdown put in place last year.

Protective masks are worn in March in Tokyo, the host of this summer’s Olympic Games.Credit…Noriko Hayashi for The New York Times

TOKYO — Japan on Friday extended a state of emergency in Tokyo and other regions until the end of May to contain a surge of coronavirus cases, casting further doubt on the country’s ability to safely host the Summer Olympics, which are scheduled to begin in 11 weeks.

Prime Minister Yoshihide Suga made the announcement at a meeting of the government’s coronavirus task force, saying that the measures were necessary because infections remain at a “high level, mainly in large cities.”

The announcement extends emergency measures imposed last month to two more prefectures, covering a total of six prefectures, including Tokyo and Osaka, that are together home to over a third of Japan’s 126 million people. Another eight prefectures will be under slightly looser restrictions.

The existing state of emergency, which were imposed to curb travel during the just-ended Golden Week holiday period and had been set to expire next week, have not slowed Japan’s fourth wave of coronavirus infections. In early March, the country recorded about 1,000 daily new. It is now recording nearly 6,000, according to a New York Times database.

Health officials say that they are seeing a growing number of cases of coronavirus variants spreading in the population, including at least 26 cases of the strain first detected in India. The authorities in Tokyo say that in four out of five cases found in the city, the infected person neither traveled abroad nor had close contact with someone who had.

The outbreak is stretching health care systems even in Japan’s biggest cities. On Thursday, there were 370 people being treated for serious cases of Covid-19 in Osaka, a prefecture of nine million people, more than the number of hospital beds available for seriously ill patients.

Japan, which has recorded more than 620,000 infections and 10,000 deaths since the start of the pandemic, has controlled the virus better than many countries. But the government has faced criticism for the sluggish pace of vaccinations, and for pledging to go ahead with the Tokyo Olympics, scheduled to begin on July 23, despite widespread public opposition.

Toru Hashimoto, a lawyer and a former governor of Osaka prefecture, said on a television show on Friday that Olympic organizers were ignoring the severity of Japan’s outbreak, and that it was inappropriate to continue holding pre-Olympic “test events” during the state of emergency, even though they are taking place without spectators.

“If the government wants to reduce the number of people in the city, it’s not a time when test events can be held,” Mr. Hashimoto said.

The government has imposed two previous states of emergency during the pandemic, although they are looser than the total lockdowns seen in many nations. The measures allow the prefectures to ask businesses to close or to restrict their hours, and to fine those that do not.

Under the extended state of emergency, people are asked not to go out for nonessential matters, especially after 8 p.m., and to refrain from traveling outside their prefectures. Karaoke parlors are asked to close, and restaurants requested not to serve alcohol, with fines of up to 300,000 yen, or $2,750, for noncompliance.

A vaccination center in Johannesburg in March.Credit…Joao Silva/The New York Times

A global debate is heating up over how to get Covid-19 vaccines to the nations most in need.

The United States supports an effort to suspend intellectual property protections on Covid-19 vaccines, and European countries say that richer nations should begin exporting more of their vaccine supply to poorer ones.

The European Union — whose approval is needed for any waiver of vaccine patents — said on Thursday that it would consider the Biden administration’s proposal. But Germany, the bloc’s largest economy, said that pushing pharmaceutical companies to share vaccine patents could have “significant implications” for the production of vaccines. The European Commission signaled it wouldn’t support the U.S. proposal.

“The limiting factor in vaccine manufacturing is production capacity and high-quality standards, not patents,” a spokeswoman for Chancellor Angela Merkel of Germany said in a statement.

Europe’s position emphasized the challenges of winning support for the waivers at the World Trade Organization, where the bloc wields significant influence, and where unanimous approval would be needed for any measure to suspend patents.

Many experts believe that the waivers are needed to expand the manufacturing of vaccines and get them to poorer parts of the world where inoculations have lagged behind those of richer countries.

Until the Biden administration’s announcement this week, the United States had been a major holdout at the W.T.O. over a proposal by India and South Africa to suspend some intellectual property protections. The move could give drugmakers access to the trade secrets of how the vaccines are made.

The pharmaceutical industry has argued that suspending patent protections would undermine risk-taking and innovation.

The debate arises amid a growing divide between wealthy nations that are slowly regaining normal life, and poorer countries that are confronting new and devastating outbreaks.

In India, which is suffering the world’s worst outbreak since the start of the pandemic, only 2.2 percent of the population is fully vaccinated, according to a New York Times database. South Africa has fully vaccinated less than 1 percent of its people. By contrast, vaccinations are slowing down in the United States — where one-third of people are fully inoculated — as they begin to pick up in Europe.

Even if a waiver receives support from the trade body, it alone would not increase the world’s vaccine supply. Large drug manufacturers in India and elsewhere would need extensive technological and other support to produce doses, experts say.

The American jobs engine slowed markedly last month, confounding rosy forecasts of the pace of the recovery and sharpening debates over how best to revive a labor market that was severely weakened by the coronavirus pandemic.

Employers added 266,000 jobs in April, the government reported Friday, far below the vigorous gains registered in March. The jobless rate rose slightly to 6.1 percent, as more people rejoined the labor force.

5

10

15%

’06

’08

’10

’12

’14

’16

’18

’20

“It turns out it’s easier to put an economy into a coma than wake it up,” Diane Swonk, chief economist for the accounting firm Grant Thornton, said of the disappointing report. “It’s understandable, it’s going to take some time, you’re not just going to snap your fingers and get everyone back to work,

Economists had forecast an addition of about a million jobs. The increase for March was revised down to 770,000 from 916,000.

The Alliance for American Manufacturing blamed supply chain problems for the loss of 18,000 jobs in that sector, noting in particular the impact that a shortage of semiconductors has had on the automotive industry.

And many offices are not yet ready to reopen fully. “I just think it takes a while for businesses to figure out how many people they need,” Ms. Swonk said, noting there is still a lot of skittishness on the part of employers and workers. “I don’t view this as terribly troubling or distressing.”

Ben Herzon, executive director of U.S. economics at the financial services company IHS Markit, agreed. “A single report with unexpected weakness in job gains is not a cause for concern,” he said. “Demand is picking up, activity is picking up.”

He noted that labor force participation had been on the upswing for two months in a row, rising to 61.7 percent last month from 61.4 percent in February.

More opportunities are bubbling up as coronavirus infections ebb, vaccinations spread, restrictions lift and businesses reopen. Job postings on the online job site Indeed are 24 percent higher than they were in February last year.

“There’s been a broad-based pickup in demand,” said Nick Bunker, who leads North American economic research at the Indeed Hiring Lab. The supercharged housing market is driving demand for construction workers. There is also an abundance of loading, stocking and other warehousing jobs — a side-effect of the boom in e-commerce.

The economy still has a lot of ground to regain before returning to prepandemic levels. Millions of jobs have vanished since February 2020, and the labor force has shrunk.

–20

–15

–10

–5 million

–8.2 million since February 2020

152.5 million jobs in February 2020

As the economy fitfully recovers, there are divergent accounts of what’s going on in the labor market. Employers, particularly in the restaurant and hospitality industry, have reported scant response to help-wanted ads. Several have blamed what they call overly generous government jobless benefits, including a temporary $300-a-week federal stipend that was part of an emergency pandemic relief program.

But there are other forces constraining the return to work. Millions of Americans have said that health concerns and child care responsibilities — with many schools and day care centers not back to normal operations — have prevented them from returning to work. Millions of others who are not actively job hunting are considered on temporary layoff and expect to be hired back by their previous employers once more businesses reopen fully. At the same time, some baby boomers have retired or switched to working part time.

An 18-year-old student received a shot of a coronavirus vaccine in Los Angeles last month.Credit…Etienne Laurent/EPA, via Shutterstock

A series of vaccine developments and the loosening of restrictions amid an improving virus trajectory may foreshadow a welcome return to normalcy for many young Americans, just as summer vacation nears.

By early next week, the Food and Drug Administration is expected to issue an emergency use authorization allowing the Pfizer-BioNTech coronavirus vaccine to be used in children 12 to 15 years old, a major step ahead in the United States’ efforts to tackle Covid-19. Pfizer also expects to seek federal clearance in September to administer the vaccine to children age 2 to 11, the company said on Tuesday.

Vaccinating children is key to raising the level of immunity in the population, experts say, and to bringing down the numbers of hospitalizations and deaths. It could also put school administrators, teachers and parents at ease if millions of adolescent students become eligible for vaccination before the next academic year begins.

The move would be a major leap forward, experts say, and comes as the director of the Centers for Disease Control and Prevention, Dr. Rochelle Walensky, said that vaccinated adolescents would be able to remove their masks outdoors at summer camps.

Yet the eagerness of parents to let their children be vaccinated is limited, according to a new national poll, which found that three in 10 parents surveyed said they would get their children vaccinated right away and 26 percent said they wanted to wait to see how the vaccine was working. About 23 percent said they would definitely not get their children vaccinated, and 18 percent said they would do so only if a child’s school required it. The survey also noted that only 9 percent of respondents said they had not yet gotten a shot but still intended to do so, one more indication that achieving widespread immunity in the United States is becoming increasingly challenging.

As health experts focus on the future of vaccinating children, a growing number of students have returned to in-person learning this school year. In March, 54 percent of K-8 schools were open for full-time in-person learning, and 88 percent were open for either full-time in-person and/or hybrid learning, according to data from a federal government survey released on Thursday. But Black, Hispanic and Asian students are enrolled in full-time in-person learning at much lower rates than white students.

The Biden administration has made an aggressive push for reopening schools in recent months, including an effort to prioritize vaccinations for teachers and employees.

An airplane landing at the airport in Frankfurt, Germany.Credit…Michael Probst/Associated Press

One returning pilot lost control of an aircraft during landing and skidded off the runway into a ditch. Another just returning from furlough forgot to activate a critical anti-icing system designed to prevent hazards in cold weather. Several others flew at the wrong altitudes, which they attributed to distractions and lapses in communication.

In all of these incidents, which were recorded on NASA’s Aviation Safety Reporting System, a database of commercial aviation mistakes that are anonymously reported by pilots and other airline crew, the pilots involved blamed the same thing for their mistakes: a lack of practice flying during the pandemic.

In 2020, global air passenger traffic experienced the largest year-on-year decline in aviation history, falling 65.9 percent compared with 2019, according to the International Air Transport Association. Flights were grounded, schedules reduced and thousands of pilots were laid off or put on furlough for up to 12 months.

As vaccination programs pick up speed across some parts of the world and travel starts to rebound, airlines are beginning to reactivate their fleets and summoning pilots back as they prepare to expand their schedules for the summer. But returning pilots can’t just pick up where they left off.

“It’s not quite like riding a bike,” said Joe Townshend, a former pilot for Titan Airways, a British charter airline, who was laid off when the pandemic hit in March last year.

“You can probably go 10 years without flying a plane and still get it off the ground,” he said, “but what fades is the operational side of things.”

Marc Johnson, a virologist at the University of Missouri, examining samples of wastewater to track the coronavirus.Credit…MichaelB Thomas for The New York Times

Although Covid-19 is primarily a respiratory disease, research conducted early in the pandemic revealed that people infected with the coronavirus often shed it in their stool. This finding, combined with the scale and urgency of the crisis, spurred immediate interest in tracking the virus by sampling wastewater.

In the past year, many scientists have been drawn into the once niche field of wastewater epidemiology. Researchers in 54 countries are tracking the coronavirus in sewage, according to the Covid19Poops Dashboard, a global directory of the projects.

These teams have found that the wastewater data seemed to accurately indicate what was happening in society. When the number of diagnosed Covid-19 cases in an area increased, more coronavirus appeared in the wastewater. Levels of the virus fell when areas instituted lockdowns and surged when they reopened.

Several teams have also confirmed that sewage can serve as an early warning system: Wastewater viral levels often peaked days before doctors saw a peak in official Covid-19 cases.

And wastewater analysis has allowed scientists to detect the arrival of certain variants in a region weeks before they are found in people — and to identify mutations that have not yet been detected in people anywhere.

The surveillance is not a replacement for clinical testing, experts said, but can be an efficient and cost-effective complement. The approach is likely to be especially valuable in low- and middle-income countries, where testing resources are more limited.

“Not every population gets tested, not everyone has access to health care,” said Dr. Marc Johnson, a virologist at the University of Missouri. “If there’s groups of people that are asymptomatic, they probably aren’t getting tested either. So you aren’t really getting the full big picture. Whereas for our testing, everyone poops.”

global roundup

Administering the AstraZeneca vaccine in Nottingham, England, last month.Credit…Oli Scarff/Agence France-Presse — Getty Images

Britain’s vaccines regulator advised on Friday that all adults under 40 in the country should be offered alternatives to AstraZeneca’s Covid-19 vaccine. It factored in concerns over very rare blood clots, the dwindling risk of severe coronavirus infection in younger adults and the availability of alternatives.

The guidance extends earlier advice that people under 30 would be offered alternative doses.

The use of the AstraZeneca vaccine has been marred by uncertainty after reports of a possible link between the doses and very rare blood clots, but public health experts around the world say that the vaccine’s benefits far outweigh the risks for most people.

Britain’s Joint Committee on Vaccination and Immunization stressed that the chances of younger people becoming seriously ill with the coronavirus had grown smaller as infection rates decrease across the country. It said that this new reality paired with the availability of alternative vaccines had factored into the decision.

In other news from around the world:

  • Australia will resume repatriation flights for Australian nationals in India after May 15, Prime Minister Scott Morrison said on Friday. The resumption will end a travel ban that made it a criminal offense for citizens and residents of Australia to enter the country from India. No other democratic nation has issued a similar ban on all arrivals.

  • Tunisia will enter a weeklong nationwide lockdown starting on Sunday, Prime Minister Hichem Mechichi said on Friday. The country of nearly 12 million people has reported 11,122 deaths and 315,000 cases, according a New York Times database.

Categories
Health

Dad and mom Are Reluctant to Get Their Kids Vaccinated for Covid-19, Ballot Exhibits

The willingness of the American public to get a Covid vaccine is reaching a saturation point, according to a new national poll. This is yet another indication that achieving widespread immunity in the United States is becoming increasingly difficult.

Only 9 percent of respondents said they hadn’t received the shot yet, but they intended to, according to the poll published in the April issue of the Kaiser Family Foundation’s Vaccine Monitor. And with federal approval of the Pfizer vaccine for teens 12-15 years old imminent, parents’ willingness to get their children vaccinated is also limited, the survey found.

Overall, just over half of respondents said they had received at least one dose of the vaccine, which is in line with data from the Centers for Disease Control and Prevention.

“We are in a new phase of vaccine demand,” said Mollyann Brodie, executive vice president of Kaiser’s Public Opinion and Survey Research Program. “There won’t be a single strategy to drive demand from all of the remaining people. There will have to be a lot of individually targeted efforts. The people who are still on the fence have logistical barriers, information needs and many do not yet know whether they are authorized. Any strategy could get a small number of people to get vaccinated, but all in all, it could be very important. “

As more scientists and public health experts conclude that the country is unlikely to reach the herd immunity threshold, the Biden government has stepped up efforts to reach those who still hesitate. On Tuesday, the government announced steps to encourage more pop-up and mobile vaccination clinics, and to distribute the recordings to general practitioners and pediatricians, as well as local pharmacies.

The survey also found that confidence in the Johnson & Johnson vaccine had taken a significant blow after the 10-day hiatus, while authorities investigated rare cases of life-threatening blood clots in people who took it. While 69 percent of respondents said they had confidence in the safety of the vaccines manufactured by Pfizer and Moderna, only 46 percent believed the vaccine from Johnson & Johnson was safe. Among adults who were not vaccinated, one in five said the news of the Johnson & Johnson shot had caused them to change their minds about a Covid-19 vaccine.

The poll found that some of the most prominent Republicans were making some progress. In this group, 55 percent said they had or intended to get a shot, up from 46 percent in March. The percentage who will “definitely not” receive the vaccine also drops from 29 percent in March to 20 percent.

The results were based on telephone surveys of a nationally representative sample of 2,097 adults from April 15 to 29.

The so-called “wait and see” group – people looking for more information before making a decision – was within 15 percent, constant from 17 percent in March. The proportion of people who said they were only vaccinated when required by employers or schools was 6 percent, compared with 7 percent in March.

The Pfizer vaccine is expected to be approved within a few days for children ages 12-15. Among parents surveyed, three in ten said they would vaccinate their children immediately, and 26 percent said they wanted to see how the vaccine works. These numbers largely reflected the zeal with which these parents themselves sought vaccination.

Updated

May 6, 2021, 9:42 a.m. ET

Similarly, 18 percent said they would only do this if a child’s school required it, and 23 percent said they would definitely not have their children vaccinated.

A consortium of universities that includes Harvard, Northeastern and Rutgers conducted online surveys during the pandemic and recently focused on parents. The group’s most recent poll, conducted in April and reaching 21,733 adults in 50 states, found that the gap between mothers and fathers when it comes to the vaccine for children had widened.

The resistance of fathers seems to be weakening somewhat and has fallen from 14 percent since February to 11 percent. But more than a quarter of mothers, the researchers say, still say they are “extremely unlikely” to vaccinate their children. Both sexes are more resistant to the vaccine in younger children than in teenagers. Other research shows that mothers tend to have more influence on the final decision than fathers.

Parents’ answers could change over time, experts say. Just as adults were far less hesitant last summer, when the vaccine was still a concept, parents who were interviewed a few weeks ago when the upcoming approval for children under 16 had not been fully discussed could possibly be more likely to point to a hypothetical situation than responding to a reality.

However, pediatricians and others who are believed to be trusted sources of information are already aware that there is still much work to be done to increase the confidence of vaccines in this newest cohort.

Dr. Sean O’Leary, a Denver pediatrician who is vice chairman of the American Academy of Pediatrics’ infectious diseases committee, predicted that just as adults had flooded Covid vaccine providers in the first few weeks of distribution, parents and pent-up teenagers would too pounce on it at the beginning.

Dr. However, O’Leary, who often speaks to pediatricians about how to motivate patients to accept vaccinations, fears the slowdown will inevitably occur. To convince reluctant parents, he said, “We need to have the vaccine available in as many places as possible.”

He added, “When parents and patients are in the pediatrician’s office and the doctor can say, ‘Hey, I have it,’ it can kick start saying, ‘Let’s go ahead and do this.” ”

Categories
World News

Covid-19 Information: Dwell Updates on Vaccine, Instances and India

Here’s what you need to know:

Credit…Saul Martinez for The New York Times

President Biden will announce Tuesday afternoon that he is directing tens of thousands of pharmacies to offer walk-in appointments for coronavirus vaccine shots, creating more pop-up and mobile clinics and shipping more doses to rural clinics, all aimed at vaccinating 70 percent of American adults at least partially by July 4.

The efforts reflect a shift in strategy by the administration as the pace of the nation’s vaccination effort slows. The federal government has also decided that if states do not order their full allocation of doses in any given week, that supply can be shifted to other states that want more.

In an afternoon address, the president plans to pledge more funding for outreach campaigns designed to convince those reluctant to get shots of the need to protect their own health and that of others. The number of shots administered daily has slowed by about half since a peak in mid-April, despite a flood of vaccine available.

Senior health officials have decided that herd immunity — the point at which the virus dies out for lack of hosts to transmit it — will likely remain elusive. But if the 70 percent to 85 percent of the population is vaccinated, the infection rate will be low enough so that normal life will be within reach, senior administration officials said.

The president will call for about 160 million adults to be fully vaccinated by Independence Day. As of Monday, more than 105 million Americans were fully vaccinated and at least 56 percent of adults — or 147 million people — had received at least one shot. That has contributed to a steep decline in infections, hospitalization and deaths across all age groups, federal officials said.

To increase availability of shots, the White House informed states that if they choose not to order their full allocation of vaccine each week, the doses will go back into a federal pool so that other states can draw on it, according to state and federal officials.

States that do not claim their full allotment one week will not be penalized because they will still be able to request the full amount the next week, officials said.

The shift, reported earlier Tuesday by The Washington Post, makes little difference to some states like Virginia that have routinely drawn down as many doses as the federal government was willing to ship. But it could help some states that are able to use more doses than the federal government allotted to them based on their population. They will now be allowed to ask for up to 50 percent more doses than the government allotted them.

Until now, White House officials had been unwilling to shift doses to states that were faster to administer them out of concern that rural areas or underserved communities would lose out to urban or richer areas where residents were more willing to get shots.

But with the pace of vaccination slowing nationwide, officials have determined that freeing up unused doses week by week will not exacerbate equity issues Some state officials have been arguing for the change for weeks.

United States › United StatesOn May 3 14-day change
New cases 50,058 –26%
New deaths 751 –3%
World › WorldOn May 3 14-day change
New cases 682,232 +6%
New deaths 10,714 +12%

U.S. vaccinations ›

Where states are reporting vaccines given

In Midtown Manhattan last week.Credit…Gabby Jones for The New York Times

Three U.S. states that were once at the center of the pandemic — New York, New Jersey and Connecticut — are taking steps to relax nearly all their coronavirus restrictions, raising hopes among many residents that life is returning to normal, but causing angst for others who are still worried about the virus.

Many people who own or work for establishments that have been hard hit by pandemic closures, like restaurants and bars, nightclubs and cultural institutions, expressed optimism.

But for some others, it may be too soon to celebrate.

Felipe Perez, 48, a construction worker who lives in Brooklyn, said that he did not trust Gov. Andrew M. Cuomo’s move to ease capacity limits for nearly all businesses starting on May 19.

“It’s too fast,” Mr. Perez added.

Mr. Cuomo’s plan says businesses should still abide by the Centers for Disease Control and Prevention’s social distancing guidelines requiring six feet of separation between people.

Businesses that monitor whether everyone inside has been vaccinated or has a negative coronavirus test can allow more people inside, as can restaurants that introduce barriers between tables.

Mr. Cuomo said that the New York City subway, which has been closed nightly to allow for thorough cleaning since last May, will resume operating 24 hours a day on May 17.

About 80,000 municipal workers in the city had already returned to the office when the governor announced the reopening plan.

Mayor Bill de Blasio said on NY1 Monday night that it was time for remote municipal workers to return, even though some may still have concerns about the virus.

Mr. de Blasio said that returning to the office was a necessary step “so we can supercharge this recovery,” adding that the city would continue safety precautions like requiring workers to wear masks in the office.

The mayor said last week that he hoped to reopen the city on July 1, more than a month after the timeline Mr. Cuomo laid out on Monday. The accelerated reopening is the latest in a series of conflicting announcements and political squabbles between the mayor and governor.

“I don’t tend to be surprised by his particular choices lately, let’s put it that way,” Mr. de Blasio said.

Some major employers in the city, like Goldman Sachs and JPMorgan Chase, will require that their employees return to the office this summer.

Other industries were somewhat taken aback by the announcement. New York City’s theaters and arts venues, for instance, will now face pressure to expedite productions and will have to work around the social distancing requirements.

Broadway is not expected to reopen until September, the Broadway League said in a recent statement. Many performing arts organizations are waiting for clarity about seating rules before putting tickets on sale.

Across the Hudson River, Al Pilone, who has owned the Our Hero sandwich shop in Jersey City, N.J., for 40 years, was reluctant to leap back to normal.

Mr. Pilone, 72, said the shop had been operating through most of the pandemic, but that he was wary about resuming indoor dining, which New Jersey establishments have been allowed to do with limitations since last summer.

He said he was waiting until 70 to 80 percent of the population is vaccinated, because “I don’t want to subject the staff to anybody if I don’t know they’ve vaccinated.”

According to a New York Times database, the average number of new cases reported daily has dropped by 44 percent or more in all three states over the past two weeks, as of Monday, and more than one-third of each state’s population has been fully vaccinated.

Still, experts have warned that in New York, and some other major cities, the slowing pace of vaccinations, the prevalence of undervaccinated areas and the spread of worrisome variants mean that the pandemic is far from over, and that reopening might be premature.

“It just seems poorly thought through, and almost a little reckless,” Dr. Denis Nash, an epidemiologist at the City University of New York, said Monday.

In the nation’s other large cities, plans for reopening have been mixed amid shifting case counts as vaccinations roll out.

In Chicago, where Mayor Lori Lightfoot announced on Tuesday that she plans to fully reopen the city by July 4, officials already have relaxed many restrictions on restaurants, churches, bars and other indoor gatherings, and allowed popular street festivals to resume this summer.

In Los Angeles, restrictions on restaurants were loosened early last month, and in Anaheim, Disneyland reopened on Friday. And that other symbol of California life seems to have returned as well: Traffic is back on the highways.

But in Seattle’s King County, where restaurants and other businesses are still under orders to have a maximum capacity of 50 percent, state leaders are considering a plan to restore more restrictions on Tuesday amid a rise in coronavirus cases and hospitalizations.

Reporting was contributed by Nate Schweber, Kevin Armstrong, Winnie Hu, Luis Ferré-Sadurní Kate Kelly, Julie Bosman, Manny Fernandez and Mike Baker.

A Covid-19 patient receives oxygen in a parked car while waiting for a hospital bed to become available in New Delhi, as a volunteer checks her oxygen saturation level.Credit…Atul Loke for The New York Times

India on Tuesday passed the milestone of 20 million reported coronavirus cases, with many more undetected, according to experts, spurring new calls for a national lockdown.

With those reported numbers, India became the second country after the United States to cross 20 million infections. Although aid has begun to pour in from other countries, hospitals are still unable to help many of those who are critically ill, and families have been left to hunt for much-needed oxygen.

Prime Minister Narendra Modi has been sharply criticized by many for underplaying the virus earlier this year, and on Tuesday the opposition leader Rahul Gandhi said a national lockdown was desperately needed, calling it “the only option.”

Mr. Gandhi accused the authorities of helping the virus spread. “A crime has been committed against India,” he wrote on Twitter.

Mr. Modi has been reluctant to impose strict nationwide lockdown measures like the ones last spring, which remained in place for months.

While experts say that the lockdown helped reduce the number of cases in the first wave of the pandemic, it also triggered the biggest internal migration since the partition of the country in 1947. Millions of workers fled the cities, dealing a blow to the economy.

The economy had been recovering in recent months, but the current wave of disease has dampened hopes for a full recovery, and Mr. Modi asked states to consider lockdowns as “a last option.” Many states, including some governed by Mr. Modi’s party and its allies, have issued stay-at-home orders.

The regional authorities in Bihar in eastern India on Tuesday ordered a two-week lockdown. The southern state of Kerala also announced restrictions this week. The states of Maharashtra, Delhi and Karnataka already have lockdowns, and many states have weekend and night curfews.

Amid the scramble to try to contain the virus, the Indian Premier League announced on Tuesday that it was suspending all the remaining matches of the season after several players and staff tested positive. The league had drawn intense criticism for going ahead with its matches in cities that have been among the worst hit.

Made up of eight teams, the Indian Premier League is the biggest cricket league in the world.

Since the league’s season started last month, some of the biggest cricket stars have traveled across the country in so-called bubbles and played in empty stadiums. But even the stringent safety protocols couldn’t stop team members from being infected. At least five people on three teams have tested positive. The competition had been scheduled to finish at the end of the month.

“These are difficult times, especially in India and while we have tried to bring in some positivity and cheer, however, it is imperative that the tournament is now suspended and everyone goes back to their families and loved ones in these trying times,” the league said in a statement.

India reported over 368,000 new cases and 3,417 deaths on Monday. It has reported more than 222,000 Covid-19 deaths, although actual figures are most likely much higher.

With aid being shipped from countries like the United States and Britain, there was hope among weary residents that the situation could start easing.

Eight oxygen generator plants from France, each of which can supply 250 hospital beds, were earmarked for six hospitals in Delhi and one each in Haryana and Telangana, states in northern and southern India. One of the generators was installed at the Narayana hospital in Delhi within hours of being delivered, according to The Times of India. Italy has also donated an oxygen generation plant and 20 ventilators.

As criticism has mounted over the delay in dispatching oxygen concentrators and other equipment, the government announced on Monday that it was waiving all duties and taxes on lifesaving equipment and relief material that had been donated. But the authorities have faced calls for more transparency on the deployment of the international aid shipments.

The Indian Red Cross receives all shipments that arrive by air, then hands them over to a government agency in charge of distributing the supplies based on regional requests. The authorities have released a list of hospitals that received aid shipments, but did not specify which equipment was going where.

Keidy Ventura, 17, received a dose of the Pfizer coronavirus vaccine in West New York, N.J., last month.Credit…Seth Wenig/Associated Press

Medical experts welcomed the news that the Pfizer-BioNTech Covid vaccine could be authorized by the Food and Drug Administration for use in adolescents ages 12 to 15 by early next week, a major step forward in the U.S. vaccination campaign.

Vaccinating children is key to raising the level of immunity in the population, experts say, and to bringing down the numbers of hospitalizations and deaths. And it could put school administrators, teachers and parents at ease if millions of adolescent students soon become eligible for vaccinations before the next academic year begins in September.

Pfizer’s trial in adolescents showed that its vaccine was at least as effective in them as it was in adults. The F.D.A. is preparing to add an amendment covering that age group to the vaccine’s existing emergency use authorization by early next week, according to federal officials familiar with the agency’s plans who were not authorized to speak publicly.

Dr. Ashish K. Jha, dean of the Brown University School of Public Health and the father of two adolescent daughters, said the approval would be a big moment for families like his.

“It just ends all concerns about being able to have a pretty normal fall for high schoolers,” he said. “It’s great for them, it’s great for schools, for families who have kids in this age range.”

This is big. FDA set to authorize Pfizer for 12-15 year-olds. Soon

About 16 million humans in this age group in US

Getting them vaccinated will help US effort to get high levels of population immunity

I have 2 such humans at home ready to get the shothttps://t.co/aXjYxE8ddL

— Ashish K. Jha, MD, MPH (@ashishkjha) May 3, 2021

But with demand for vaccines falling among adult Americans — and much of the world clamoring for the surplus of American-made vaccines — some experts said the United States should donate excess shots to India and other countries that have had severe outbreaks.

“From an ethical perspective, we should not be prioritizing people like them over people in countries like India,” Dr. Rupali J. Limaye, a Johns Hopkins University researcher who studies vaccine use, said of adolescents.

Dr. Jha said that the United States now had a big enough vaccine supply to both inoculate younger Americans and aid the rest of the world. As of Monday, the United States had about 65 million doses delivered but not administered, including 31 million doses of the Pfizer-BioNTech vaccine, according to figures collected by the Centers for Disease Control and Prevention.

More than 105 million adults in the United States have been fully vaccinated. But the United States is in the middle of a delicate and complex push to reach the 44 percent of adults who have not yet received even one shot.

While adolescents so far appear to be mostly spared from severe Covid-19, Dr. Anthony S. Fauci, the Biden administration’s top Covid adviser, has repeatedly stressed the importance of expanding vaccination efforts to include them and even younger children. In March, Dr. Fauci said that he expected that high schoolers could be vaccinated by fall and elementary school students by early 2022.

Dr. Richard Malley, a pediatric infectious disease specialist at Boston Children’s Hospital, said that immunizing adolescents was worthwhile because they can spread the virus, even if they transmit it at a lower rate than adults.

A group of activists gathered outside City Hall to call for an extension of the moratorium on evictions and for a roll back of the city’s rents for tenants in New York on Monday.Credit…Justin Lane/EPA, via Shutterstock

New York State lawmakers on Monday passed legislation that would extend a statewide moratorium on residential and commercial evictions through Aug. 31.

The extension would provide additional relief for tenants, who have had broad protection from being taken to housing court since the start of the pandemic, just as New York is expected to start distributing $2.4 billion in rental assistance to struggling renters.

That financial aid will provide up to a year’s worth of unpaid rent and utilities, a financial lifesaver for not just tenants but also their landlords, many of whom have endured more than a year of little income.

Together, the moratorium extension and rental assistance comes just as New York State, along with New Jersey and Connecticut, announced plans to lift almost all their pandemic restrictions later this month, offering a chance to boost the economy a year after the region became a center of the pandemic.

The state’s eviction moratorium would extend the state’s previous protections, which expired on May 1, and goes further than the nationwide moratorium, which expires on June 30 and were imposed by the Centers for Disease Control and Prevention.

The new state eviction order would go into effect once Governor Andrew M. Cuomo signs it into law.

Since the start of the pandemic, nearly 49,000 eviction cases have been filed in New York City Housing Court, the highest number among any American city, according to the Eviction Lab at Princeton University. While most evictions are on pause, cases can still be filed with the courts.

An analysis of court data shows that the areas in New York City hit hardest by the virus — largely Black and Latino neighborhoods in the Bronx and Queens — have had the highest number of eviction cases. On average, renters owe $8,150 in unpaid rent, the Association for Neighborhood and Housing Development, a coalition of housing nonprofits.

Tenants cannot be evicted if they can show a financial or health hardship because of the pandemic. Lawmakers said that without an eviction moratorium, hundreds of thousands of New Yorkers, if not more, could be at risk of losing their homes.

In addition to protections for renters, the new legislation in New York would also safeguard smaller landlords who have been unable to pay their mortgages, protecting them from tax lien sales or foreclosures. Commercial tenants with fewer than 50 employees can also file a hardship declaration to receive eviction protections.

global roundup

Prime Minister Scott Morrison of Australia spoke to reporters in Sydney last month.Credit…Joel Carrett/EPA, via Shutterstock

The Australian authorities have faced a growing backlash from human rights groups and opposition politicians after they barred Australian citizens stranded in India from coming home, prompted by India’s record-breaking Covid-19 outbreak.

It is a travel ban with no equivalent in other democratic countries. Introduced on Monday and in place until May 15, it wields a possible punishment of up to five years in prison and a fine equivalent to about $50,000 for anyone trying to return from India. It is believed to be the first time that Australia has made it a criminal offense for its citizens and permanent residents to enter.

Michael Slater, an Australian cricket commentator who was in India covering the sport, said in a tweet on Monday that the ban was a “disgrace” and a form of government neglect. “Blood on your hands PM,” Mr. Slater wrote, referring to Prime Minister Scott Morrison.

After the policy was announced, the Australian Human Rights Commission said it raised “serious human rights concerns,” and Tim Soutphommasane, Australia’s former race discrimination commissioner, wrote in The Guardian that the measure “undermines the very status of citizenship.”

On Tuesday, Mr. Morrison said that it was “highly unlikely” that anyone would be fined or go to jail for breaching the ban.

In an interview with the Australian broadcaster 9News, he said that the likelihood of imprisonment under the rule was “pretty much zero” and defended it as a necessary safety measure.

“I’m not going to fail Australia,” Mr. Morrison said. “I’m going to protect our borders at this time.”

In other news from around the world:

  • The European Union’s drug regulator has begun a rolling review of China’s Sinovac vaccine for Covid-19. The European Medicines Agency said on Tuesday that it would review laboratory and clinical-trial data provided by the company until it could determine that the vaccine’s benefits outweighed its risks and if it was fit to receive authorization. The World Health Organization has also been reviewing Sinovac’s vaccine and one manufactured by the Chinese state-owned company Sinopharm, with decisions expected this month.

  • Tourists traveling to Italy won’t need to quarantine starting after mid-May, Prime Minister Mario Draghi announced on Tuesday, anticipating the introduction of a European Digital Green Pass for travelers. Visitors will be able to enter and travel through the country only if they are fully vaccinated or can show a negative PCR test taken in the 72 hours before traveling to Italy. They will still need to respect restrictions like wearing masks and keeping social distance. “We look forward to welcoming you again soon,” Mr. Draghi said at a news conference.

  • After a major dairy product manufacturer in South Korea was accused of deliberately spreading misinformation that one of its drinks could fend off the coronavirus, the chairman and chief executive tendered their resignations this week. Local news media reported that sales of the Bulgaris yogurt drink and stocks for Namyang Dairy Products both soared after a research director claimed at a conference last month that the drink reduced the chances of contracting the coronavirus by more than 70 percent. Korea’s Ministry of Food and Drug Safety accused the company of illegally spreading misleading information, and the police raided Namyang’s headquarters and factory last week.

President Xi Jinping on a screen in Beijing last month. The Chinese government’s aggressive brand of “wolf warrior” diplomacy has drawn criticism from other countries.Credit…Greg Baker/Agence France-Presse — Getty Images

Even in China, where propaganda has become increasingly pugnacious, the display was jarring: A photograph of a Chinese rocket poised to blast into space juxtaposed with a cremation pyre in India, which has been overwhelmed by a wave of coronavirus infections.

“Chinese ignition versus Indian ignition,” the title read.

The image drew a backlash from internet users who called it callous, and it was taken down on the same day by the Communist Party-run news service that posted it. But it has lingered as a provocative example of a broader theme running through China’s state-run media, which often celebrates the country’s success in curbing coronavirus infections while highlighting the failings of others.

Chinese leaders have expressed sympathy and offered medical help to India, and the controversy may soon pass. But it has exposed how swaggering Chinese propaganda can collide with Beijing’s efforts to make friends abroad.

“You’ve had this growing tension between internal and external messaging,” said Mareike Ohlberg, a senior fellow in the Asia Program at the German Marshall Fund in Berlin who studies Chinese propaganda. Ms. Ohlberg said of the Chinese authorities, “They have an increasing number of interests internationally, but ultimately what it boils down to is that your primary target audience still lives at home.”

A woman pleaded for oxygen for her husband at a Sikh temple, in Ghaziabad, India, on Monday.Credit…Adnan Abidi/Reuters

Savita Mullapudi, an international development consultant in Pittsburgh, heard the ping of a WhatsApp message on her phone around 4 p.m. on Thursday. The sender was a former colleague who, like her, was an Indian immigrant who had lived in the United States for years. He had an urgent favor to ask.

With India’s health care system overwhelmed by the nation’s unprecedented Covid-19 surge and hospitals running out of lifesaving oxygen, an Indian charity was scrambling to find oxygen concentrators, which filter oxygen from the air. One manufacturer was based in Pittsburgh. Could Ms. Mullapudi visit the site to vet the equipment?

Like many members of the Indian diaspora who have watched and mobilized from afar as a deadly second wave of the coronavirus has swept across India in recent weeks, Ms. Mullapudi, whose parents and in-laws live there, leapt at the opportunity to help. She called the company a few minutes later but was told the earliest date for a visit was May 8 — far too late.

So Ms. Mullapudi, 44, said she did “the next-best thing.” She asked a few local doctor friends to tap their networks in Pittsburgh and across Pennsylvania for their opinions of the company and the quality of its products.

By 9 a.m. the next day, she had received texts and long emails from medical professionals and hospital executives with “rave reviews” of the manufacturer, she recalled, as well as detailed descriptions of the machines’ electricity costs and how long they lasted.

Credit…Aria M. Narasimhan

“The minute I said ‘India Covid,’ I was inundated with responses,” Ms. Mullapudi said. “These networks of people that we all work with or know as friends just churned it around, and that’s what really gave the organization confidence to go ahead.”

Before noon on Friday, the foundation ordered more than 400 oxygen concentrators to be flown to India. Though Ms. Mullapudi described her role as just “one drop in an ocean,” she acknowledged the profound impact of so many small acts of human kindness in the face of such dire challenges.

“Eventually it’s just people helping people,” she said. “That’s the story of hope.”

Pfizer’s vaccine is disproportionately reaching the world’s rich.Credit…Dado Ruvic/Reuters

On Tuesday, Pfizer announced that its Covid vaccine brought in $3.5 billion in revenue in the first three months of this year, nearly a quarter of its total revenue. The vaccine was, far and away, Pfizer’s biggest source of revenue, report Rebecca Robbins and Peter S. Goodman of The New York Times.

The company did not disclose the profits it derived from the vaccine, but it reiterated its previous prediction that its profit margins on the vaccine would be in the high 20 percent range. That would translate into roughly $900 million in pretax vaccine profits in the first quarter.

Pfizer has been widely credited with developing an unproven technology that has saved an untold number of lives.

But the company’s vaccine is disproportionately reaching the world’s rich — an outcome, so far at least, at odds with its chief executive’s pledge to ensure that poorer countries “have the same access as the rest of the world” to a vaccine that is highly effective at preventing Covid-19.

As of mid-April, wealthy countries had secured more than 87 percent of the more than 700 million doses of Covid-19 vaccines dispensed worldwide, while poor countries had received only 0.2 percent, according to the World Health Organization. In wealthy countries, roughly one in four people has received a vaccine. In poor countries, the figure is one in 500.

Foreign domestic workers waited to be tested for the coronavirus in Hong Kong on Sunday.Credit…Jerome Favre/EPA, via Shutterstock

The Hong Kong government on Tuesday backpedaled from a plan to require coronavirus vaccinations for all foreign domestic workers after several days of sharp criticism from foreign diplomatic missions and some residents, who called the requirement discriminatory.

Officials had announced on Friday that the domestic workers — largely low-paid, female migrants from Southeast Asia who clean, cook and perform other household tasks — would have to be vaccinated in order to renew their employment contracts. The government has not issued vaccination requirements for any other group in the city, including other foreign workers.

But officials said it was necessary after two domestic workers recently tested positive for variant strains of the coronavirus. Sophia Chan, the secretary for food and health, said that because domestic workers had a habit of “mingling” with each other during their time off — which, under Hong Kong law, is only one day a week — the entire group of roughly 370,000 workers was considered high-risk.

Hong Kong’s vaccine uptake has been slow, and none of its major outbreaks of the coronavirus have been attributed to domestic workers gathering on their days off.

The announcement provoked an immediate backlash, with critics alleging that the government was making scapegoats of the domestic workers, who make up about 5 percent of Hong Kong’s population of 7.5 million and have long endured poor treatment.

The consuls general of the Philippines and Indonesia — the two main sources of Hong Kong’s foreign domestic workers — said that if there were vaccination requirements, they should be applied to all foreign workers. The Philippines’ outspoken foreign secretary tweeted that the move “smacks of discrimination.”

The government denied that it was discriminating against the workers, but on Tuesday, Carrie Lam, the city’s chief executive, said that in light of the “discussion and attention” that the plan had elicited, she would ask the labor department to “study the specific situation again” and consult foreign consulates. A decision on the plan would be announced later, she said.

Still, the government has said that all foreign domestic workers who have not been fully vaccinated must be tested for the coronavirus by May 9.

Vaccinations have begun at Castello di Rivoli, a contemporary museum near Turin, Italy. The art installation is a wall painting by Claudia Comte, a Swiss artist.Credit…Alessandro Grassani for The New York Times

These days, visitors to the website of one of Italy’s most renowned contemporary art museums are met with a twofold invitation: “Book your visit in advance” and “Book your vaccination.”

The Castello di Rivoli, once a palace owned by the Savoy dynasty, recently became one of several Italian museums to join the country’s vaccine drive, following in the footsteps of cultural institutions throughout Europe.

With the rallying cry of “Art Helps,” the museum near Turin has set aside its third-floor galleries for a vaccination center run by the local health authorities. During their shots, patients can enjoy the wall paintings by Claudia Comte, a Swiss artist.

Comte worked with the composer Egon Elliut to create a soundscape that evokes “a dreamlike feeling,” the artist said, and lulls vaccine recipients as they move from room to room before and after the shot.

“Art has an extraordinarily important effect on well-being,” said Carolyn Christov-Bakargiev, the museum’s director. She said that she couldn’t have commissioned “a more perfect” backdrop than Comte’s works for a “space to merge the art of healing the body and the art of healing the soul and the mind,” noting that in Italian the words for “to heal” and “curator” came from the same Latin word, “curo.” In history, she said, some of the first museums were former hospitals.

President Samia Suluhu Hassan of Tanzania has taken a different approach from her virus-denying predecessor, stating that the nation could not ignore the pandemic.Credit…Associated Press

Less than two months after Tanzania’s first female president took office, the government on Monday announced new steps to tackle the pandemic, in what could be the start of a shift for the East African nation, whose former leader had denied the seriousness of the virus before he died in March. His political opponents said he had died from Covid, but his government denied it.

Beginning Tuesday, all travelers arriving in Tanzania are required to present proof of a negative coronavirus test taken in the previous 72 hours and must pay for a rapid test after they land, the health ministry said.

The new president, Samia Suluhu Hassan, who was sworn into office in March, formed a committee in her first weeks in office to advise her on the status of pandemic in the country, and the steps needed to keep people safe.

Ms. Hassan, however, has not spoken publicly about whether she supports vaccinations or whether vaccines are even available in the country. She has also drawn criticism at times for not wearing a mask, including at her own swearing-in ceremony, and for addressing large gatherings of unmasked supporters. But she has worn one during foreign trips.

Under the previous president, John Magufuli, Tanzania stopped sharing data about coronavirus cases or deaths with the World Health Organization in April 2020. Ms. Hassan’s government also has not submitted any data to the World Health Organization on new cases and deaths, and has not said if, or when, Tanzania would change course.

Ms. Hassan has stated, nevertheless, that Tanzania could not ignore the virus.

“We cannot isolate ourselves as an island,” she said in a speech last month.

The new measures announced on Monday appear to be focused on stopping coronavirus at the country’s borders. The health ministry said that foreigners arriving from countries with new Covid-19 variants would be placed in a mandatory 14-day quarantine at a government-designated facility, while returning residents would be permitted to isolate themselves in their homes.

Truck drivers crossing borders will be permitted to stop only at designated locations and could be tested for the coronavirus at random while in Tanzania.

The moves signal a departure from the blithe approach taken by Mr. Magufuli, the former president. He long opposed masks and social distancing measures, promoted unproven treatments as cures, argued that vaccines didn’t work and declared that God had helped Tanzania eradicate the virus.

Two weeks before he died, Mr. Magufuli changed course and told citizens to take precautions against the virus, including wearing masks and observing social distancing.

Cafes and restaurants have reopened in Greece for sit-down service for the first time in nearly six months.Credit…Petros Giannakouris/Associated Press

Greece has reopened to many overseas visitors, including from the United States, jumping ahead of most of its European neighbors in restarting tourism, even as the country’s hospitals remain full and more than three-quarters of Greeks are still unvaccinated.

It’s a big bet, but given the importance of tourism to the Greek economy — the sector accounts for one quarter of the country’s work force and more than 20 percent of gross domestic product — the country’s leaders are eager to roll out the welcome mat.

In doing so, Greece has jumped ahead of other European countries. On Monday, the European Commission, the executive arm of the European Union, said it would recommend its member states to allow visitors who have been vaccinated. But it remains up to individual countries to set up their own rules.

“We welcome a common position” on restarting tourism in the European Union, Greece’s tourism minister, Harry Theoharis, said in an interview. “All we’re saying is that this has to be forthcoming now. We cannot wait until June.”

Park Avenue between 46th and 59th Streets will go through renovation over the next few years, giving the city a unique opportunity to rethink the famed malls.Credit…Oscar Durand for The New York Times

At a moment when the pandemic has unleashed demand for open space, plans could transform the medians of Park Avenue in Manhattan and restore them to their original splendor.

Among the options New York City is considering: bringing back chairs and benches, expanding the median, eliminating traffic lanes and carving out room for bike and walking paths.

The revamping of Park Avenue is being driven by a major transit project below ground. A cavernous shed used by Metro-North commuter trains that travel in and out of Grand Central Terminal is over a century old and in need of major repairs.

The work requires ripping up nearly a dozen streets along Park Avenue, from East 46th to East 57th Streets, making possible a new vision.

Removal of traffic lanes is likely to elicit backlash from drivers who complain that pedestrian plazas and bike lanes across the city have made it difficult to get around.

But others say the city would be more livable with fewer cars, making streets safer for pedestrians and bicyclists as well as polluting less.

Categories
Business

What to anticipate as reside music concert events begin to reemerge put up Covid-19

A concert in Red Rocks Park and the Amphitheater outside of Denver.

John P Kelly | The Image Bank unpublished | Getty Images

When 31-year-old Riley Cash from Denver received his second vaccine earlier this month, the next thing on the agenda was a concert at nearby Red Rocks Park and Amphitheater.

The outdoor venue reopened this month with limited capacity and four night shows by a band called Lotus.

The fact that concerts were already coming back came as a surprise, Cash said. But after working from home for a year, he was dying to see one of his favorite acts live.

Tickets cost about $ 91 per person, more than Cash expected. But he said he considered himself and his friend lucky to be able to get tickets within days of the sale.

More from Personal Finance:
Hotel prices are rising as the demand for travel increases
When it comes to finding love, so much debt is a deal breaker
This is what travel could look like after a pandemic

“I just want to do something,” he said.

Some smaller outdoor and outdoor concerts are starting to open up, offering shows of limited capacity in hopes of finding attendees who feel the same way.

Anecdotally, these venues say they find it easy to fill the spots they can offer.

“We haven’t put a single show up for sale that didn’t blow up right away,” said spokesman Brian Kitts of Red Rocks, near Morrison, Colorado.

The outdoor yoga series that Red Rocks is selling is also selling out quickly, he said.

While it still feels a long way off for other indoor forms of entertainment such as opera and ballet to reopen, the first sales of the available events have gotten off to a stronger start than expected, Kitts said.

That’s a big deal for the urban venue, which lost roughly $ 52 million over the past year.

“Nobody saw this coming,” said Kitts.

“There are 400 people working at the venue every night, and all of those jobs were only gone overnight,” he said.

Dixie Strange, 30, during a morning yoga session at Red Rocks Amphitheater in Morrison, Colorado on August 22, 2020.

Mark Makela | Getty Images News | Getty Images

Ticket prices haven’t generally gone up at the start of the show season thanks to the bands and promoters, Kitts said.

However, there are new Covid-19 protocols.

There are no temperature checks on the door or requirements to prove a vaccine or a negative Covid-19 test.

However, other precautions were taken. There is a distance of two meters between groups of ticket holders, who now only occupy every second row. Masks are required in interiors such as bathrooms or in the visitor center.

The venue has also implemented touchless payment systems for all transactions.

We haven’t put a single show up for sale that wasn’t immediately blown out. “

Brian Kitts

Red Rocks spokesperson

Some of the concert dates that were canceled in 2020 have been postponed to 2021. Still, new acts are pushing not to be added to the calendar until October or even November, Kitts said.

“We will never again take for granted the ability to gather together and see a concert or go to a sporting event,” said Kitts.

While some venues report strong initial ticket sales, a recent Bankrate.com survey found that only 16% of adults bought tickets to a live event.

Concerts or music festivals were the most popular with 8% of those surveyed. Live theater or comedy followed, 6%; Professional sports or college games, 5%; or other live events that require tickets, 2%.

One reason for the lackluster poll results, which came in late March, could be that consumers are still smart about the money they lost in last year’s events, said Ted Rossman, senior industry analyst at Bankrate.com.

“We found last year that basically half of the people who had tickets to these events last year lost money,” said Rossman. “And I think a lot of people are shy about it.”

Buying tickets now presents a “calculated risk” that you may get your money or credit back if the events don’t go ahead as planned.

However, Bankrate.com found that people spend an average of $ 227 on concerts and music festivals, $ 191 on comedy or live theater, and $ 387 on games and sporting events when buying tickets.

Some of these costs may include additional security protocols.

For some venues, implementing these processes was key to getting attendees back in the door.

Rhett Miller will perform at City Winery NYC in New York City on April 3, 2021.

Taylor Hill | Getty Images Entertainment | Getty Images

At the City Winery in New York City, the seating capacity will be expanded from the current 100 participants per show to 150 from May 1st.

This date will also usher in a new vaccination-only policy for concert-goers who can use the CLEAR app to provide evidence and fill out a questionnaire in advance. Those who have not received the vaccination can bypass the rule by having a Covid-19 test in advance or on-site on the day of the event.

“We are excited to be driving this forward, so it is psychological comfort to be in a bubble knowing that everyone around you has been vaccinated too,” said Michael Dorf, CEO and Chairman of City Winery.

Even so, the venue has no plans to relax protocols, particularly with regard to wearing masks, until the government gives the OK, Dorf said.

The City Winery has dealt with varying capacity rules and restrictions at its other locations in cities like Nashville, Tennessee. Atlanta and Chicago.

Seeing the live music ecosystem reappear was deeply powerful and very moving.

Michael Dorf

CEO and Chairman of City Winery

One constant, however, remains the same: the fans’ appetite to see live music again.

“Everything we can offer for sale now … is sold out very quickly, enthusiastically,” said Dorf.

Like many other venues, City Winery struggled to close last year as it faced ongoing rents, utility bills, and payrolls.

But it has tried to keep its ticket prices in check, which largely depend on how much the artists paid. Several night shows have helped offset limited ticket sales due to lower capacity.

As the pandemic continues to subside, Dorf also hopes these restrictions come with it.

The introductory joke he tells the audience before each show is always the same, he said.

“Please don’t get used to so much space out there,” said Dorf. “We’ll rush you and get you in here as soon as we can safely.”

The biggest win was seeing the joy the performers feel when they get back on stage and the audience when they see it.

“Seeing the live music ecosystem reappear was deeply powerful and very moving,” said Dorf.